Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery

Researchers at BHP founder-member the University of Birmingham are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs. The encounter complex is formed when the COVID-19 spike latches onto a binding site on an ACE-2 receptor, which is a … Continue reading “Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery”

New gene therapy innovation centre to turn scientific discoveries into life-changing treatments

BHP founder-member the University of Birmingham is set to play a key role in a pioneering new gene therapy innovation centre which will advance scientific discoveries into promising treatment options for millions of patients with life-threatening diseases. The Gene Therapy Innovation and Manufacturing Centre (GTIMC) will be led by the University of Sheffield in collaboration … Continue reading “New gene therapy innovation centre to turn scientific discoveries into life-changing treatments”

£1.1m funding to improve uptake of at-home dialysis

A new study being carried out in collaboration with BHP founder-member the University of Birmingham could save the NHS up to £45m over three years by increasing the number of dialysis patients whose treatment takes place at home. Funded by the National Institute for Health Research (NIHR), the study will focus on the reasons why home therapies … Continue reading “£1.1m funding to improve uptake of at-home dialysis”

Drug dosing technology to improve children’s cancer treatment

A new project has been launched in collaboration with BHP founder-member the University of Birmingham aimed at aiding more precise drug dosing in children with cancer. Children receiving chemotherapy treatment each process the drugs differently, leading to inconsistencies in drug concentrations in the blood (known as drug exposure). Patients may not receive enough of the … Continue reading “Drug dosing technology to improve children’s cancer treatment”

Increased COVID-19 risks to pregnant women highlighted by global research review

Pregnant women remain at increased risk of severe COVID-19, and their risk of being admitted to intensive care or needing invasive ventilation is higher than non-pregnant reproductive aged women with the virus, an ongoing global study has found. Pregnant women with COVID-19 are at increased risk of severe COVID-19, particularly if they are from ethnic … Continue reading “Increased COVID-19 risks to pregnant women highlighted by global research review”